patent/BR-112012016392-A2

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112012016392-A2

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
filingDate	2010-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0ebb522d62d1604f8f48a5030f0201c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e56dd2f80586fdf8506b2b7750ffe5c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_882d3ed926fdf977b48b11c045906b64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e585618867d29e964cbd4c183fce3f81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7aa5895eb35fc0cba0a701e30637341c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05805d79aecf67877db8cb72305a4162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d60c4380ce0056777c7b84eeba6b9b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_959c617e84595ad16c510ab28947e70a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09f02602aee600e0dfda3c2d2f9ab0f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac7f575403e135a59c9aec6183f81cd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_349c689c1a5b08ba1939897b96896570 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42ac151e5dff9f742b05203442e6099f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eddc83839fb8221cafd5243d36129e40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ccf39248f93777c3b556131d1927eba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f68fffd0820cdec124e9442b36d60ba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a0ca4d421ac4557678aff3c5716df88
publicationDate	2017-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	BR-112012016392-A2
titleOfInvention	THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE
abstract	THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE. The present invention relates to methods of treating disorders using compounds that modulate striatal-enriched tyrosine phosphatase (STEP) which are described herein. Exemplary disorders include schizophrenia and cognitive impairment.
priorityDate	2009-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484026 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057

Total number of triples: 63.